XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT

XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 02.05.2024

The following instruments on Boerse Frankfurt do have their last trading day on 02.05.2024
Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 02.05.2024

ISIN Name
AU000000BWX7 BWX LTD
CA0079755017 AETERNA ZENTARIS INC.
CA03949L2003 ARCHER EXPLORATION CORP.
CA89854F1062 TRYP THERAPEUTICS INC.
DE0007686826 GOLD-ZACK AG NA O.N.
FR0012816825 BIOPHYTIS NAM. EO -,002
IE00BJ3V9050 ENDO INTERNATL DL-,0001
LU2109786827 AIS-A.MSCI EMESGUS ETFDRC
US0395872098 ARCIMOTO INC. NEW
US78418A5056 SAFE + GREEN HOLD. DL-,01
US98585K8624 YIELD 10 BIOSCIENCE
XS2297551371 LEVERAGE SHA ETP 2071
XS2297551454 LEVERAGE SHA ETP 2071
XS2337093525 LEVERAGE SHA ETP 2071

6 Richtige für 2025

Das Börsenjahr 2025 klopft schon an die Tür – und wie immer geht es um die Frage: Welche Aktien werden die großen Gewinner sein? Die Auswahl an Möglichkeiten ist riesig, doch nur ein paar echte Volltreffer stechen heraus.

Ob stabiler Dividenden-Lieferant, Tech-Pionier oder spekulative Wette im Krypto-Bereich – wir haben die Märkte für Sie ausgiebig durchforstet und präsentieren Ihnen 6 Unternehmen, die große Chancen auf außergewöhnliche Kurssteigerungen besitzen. Hier sind, speziell für Sie, Ihre „6 Richtigen“ für 2025.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche Unternehmen das Potenzial besitzen, im kommenden Jahr richtig durchzustarten!

Hier klicken

Zeit	Aktuelle Nachrichten
02.05.	XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 02.05.2024		The following instruments on Boerse Frankfurt do have their last trading day on 02.05.2024Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 02.05.2024ISIN NameAU000000BWX7 BWX... ► Artikel lesen

Zeit

Aktuelle Nachrichten

02.05.

XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 02.05.2024

Zeit	Aktuelle Nachrichten
02.12.	BIOPHYTIS: Biophytis participates in the 17th SCWD Congress and hosts an Obesity Investor Call
11.10.	Biophytis GAAP EPS of -€9.48
30.09.	Biophytis Publishes First-Half Financial Results and Provides an Update on its Business Activities	PARIS, FRANCE and CAMBRIDGE, MA / ACCESSWIRE / September 30, 2024 / Biophytis SA (Euronext Growth Paris:ALBPS) ("Biophytis" or the "Company"), a clinical-stage biotechnology company focused on developing... ► Artikel lesen
30.09.	BIOPHYTIS: Biophytis Publishes First-Half Financial Results and Provides an Update on its Business Activities
30.09.	Biophytis SA - 6-K, Report of foreign issuer

Zeit

Aktuelle Nachrichten

02.12.

BIOPHYTIS: Biophytis participates in the 17th SCWD Congress and hosts an Obesity Investor Call

11.10.

Biophytis GAAP EPS of -€9.48

30.09.

Biophytis Publishes First-Half Financial Results and Provides an Update on its Business Activities

PARIS, FRANCE and CAMBRIDGE, MA / ACCESSWIRE / September 30, 2024 / Biophytis SA (Euronext Growth Paris:ALBPS) ("Biophytis" or the "Company"), a clinical-stage biotechnology company focused on developing...
► Artikel lesen

30.09.

BIOPHYTIS: Biophytis Publishes First-Half Financial Results and Provides an Update on its Business Activities

30.09.

Biophytis SA - 6-K, Report of foreign issuer

Zeit	Aktuelle Nachrichten
02.05.	XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 02.05.2024		The following instruments on Boerse Frankfurt do have their last trading day on 02.05.2024Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 02.05.2024ISIN NameAU000000BWX7 BWX... ► Artikel lesen

Zeit

Aktuelle Nachrichten

02.05.

XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 02.05.2024

Zeit	Aktuelle Nachrichten
12.11.	COSCIENS Biopharma Inc. Reports Third Quarter 2024 Financial Results and Provides Update on Advancements with Merger Integration Process and Ongoing Development Programs	Continued execution on merger integration with Ceapro Inc. and advancements across business Company ended the quarter with US$20.0 million in cash TORONTO, ONTARIO, Nov. 12, 2024 (GLOBE... ► Artikel lesen
12.11.	COSCIENS Biopharma Inc. - 6-K, Report of foreign issuer
08.10.	Cosciens Biopharma Inc: Cosciens Biopharma director Egbert resigns
08.10.	COSCIENS Biopharma strukturiert Vorstand um
08.10.	COSCIENS Biopharma reshuffles board of directors

Zeit

Aktuelle Nachrichten

12.11.

COSCIENS Biopharma Inc. Reports Third Quarter 2024 Financial Results and Provides Update on Advancements with Merger Integration Process and Ongoing Development Programs

Continued execution on merger integration with Ceapro Inc. and advancements across business Company ended the quarter with US$20.0 million in cash TORONTO, ONTARIO, Nov. 12, 2024 (GLOBE...
► Artikel lesen

12.11.

COSCIENS Biopharma Inc. - 6-K, Report of foreign issuer

08.10.

Cosciens Biopharma Inc: Cosciens Biopharma director Egbert resigns

08.10.

COSCIENS Biopharma strukturiert Vorstand um

08.10.

COSCIENS Biopharma reshuffles board of directors

Zeit	Aktuelle Nachrichten
Mo	Endo, Inc.: Endo Announces Publication of Peyronie's Disease Self-Assessment Screening App Article in Peer-Reviewed Translational Andrology and Urology	MALVERN, Pa., Dec. 16, 2024 /PRNewswire/ -- Endo, Inc. (OTCQX: NDOI) announced today the publication of the Peyronie's disease (PD) self-assessment screening app by the peer-reviewed journal... ► Artikel lesen
10.12.	Endo, Inc.: Endo Launches Doxycycline for Injection, USP	MALVERN, Pa., Dec. 10, 2024 /PRNewswire/ -- Endo, Inc. (OTCQX: NDOI) announced today that it has begun shipping doxycycline for injection, USP 100 mg/vial, an AP-rated version of DOXY 100. "We're... ► Artikel lesen
09.12.	Endo, Inc.: Endo Receives U.S. FDA Approval of Manufacturing Facility in Indore, India	20,000-square-foot site increases Endo's sterile injectable production capacityThis marks the site's first U.S. FDA approval Endo is investing and innovating in its Injectable Solutions businessMALVERN... ► Artikel lesen
02.12.	Endo, Inc.: Endo Launches ADRENALIN Ready-to-Use Premixed Bag, the First and Only FDA-Approved, Manufacturer-Prepared Epinephrine Premixed IV Bag	MALVERN, Pa., Dec. 2, 2024 /PRNewswire/ -- Endo, Inc. (OTCQX: NDOI) announced today the launch of its ADRENALIN® (epinephrine in 0.9% sodium chloride injection) ready-to-use premixed bag... ► Artikel lesen
20.11.	Endo, Inc.: John Elway Teams Up with Endo to Share Update on Dupuytren's Contracture and Treatment with XIAFLEX (collagenase clostridium histolyticum)	MALVERN, Pa., Nov. 20, 2024 /PRNewswire/ -- Endo, Inc. ("Endo") (OTCQX: NDOI) announced today that John Elway will share an update about his Dupuytren's contracture patient journey, including... ► Artikel lesen

Zeit

Aktuelle Nachrichten

Endo, Inc.: Endo Announces Publication of Peyronie's Disease Self-Assessment Screening App Article in Peer-Reviewed Translational Andrology and Urology

MALVERN, Pa., Dec. 16, 2024 /PRNewswire/ -- Endo, Inc. (OTCQX: NDOI) announced today the publication of the Peyronie's disease (PD) self-assessment screening app by the peer-reviewed journal...
► Artikel lesen

10.12.

Endo, Inc.: Endo Launches Doxycycline for Injection, USP

MALVERN, Pa., Dec. 10, 2024 /PRNewswire/ -- Endo, Inc. (OTCQX: NDOI) announced today that it has begun shipping doxycycline for injection, USP 100 mg/vial, an AP-rated version of DOXY 100. "We're...
► Artikel lesen

09.12.

Endo, Inc.: Endo Receives U.S. FDA Approval of Manufacturing Facility in Indore, India

20,000-square-foot site increases Endo's sterile injectable production capacityThis marks the site's first U.S. FDA approval Endo is investing and innovating in its Injectable Solutions businessMALVERN...
► Artikel lesen

02.12.

Endo, Inc.: Endo Launches ADRENALIN Ready-to-Use Premixed Bag, the First and Only FDA-Approved, Manufacturer-Prepared Epinephrine Premixed IV Bag

MALVERN, Pa., Dec. 2, 2024 /PRNewswire/ -- Endo, Inc. (OTCQX: NDOI) announced today the launch of its ADRENALIN® (epinephrine in 0.9% sodium chloride injection) ready-to-use premixed bag...
► Artikel lesen

20.11.

Endo, Inc.: John Elway Teams Up with Endo to Share Update on Dupuytren's Contracture and Treatment with XIAFLEX (collagenase clostridium histolyticum)

MALVERN, Pa., Nov. 20, 2024 /PRNewswire/ -- Endo, Inc. ("Endo") (OTCQX: NDOI) announced today that John Elway will share an update about his Dupuytren's contracture patient journey, including...
► Artikel lesen

Zeit	Aktuelle Nachrichten
02.05.	XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 02.05.2024		The following instruments on Boerse Frankfurt do have their last trading day on 02.05.2024Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 02.05.2024ISIN NameAU000000BWX7 BWX... ► Artikel lesen

Zeit

Aktuelle Nachrichten

02.05.

XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 02.05.2024

Zeit	Aktuelle Nachrichten
Mi	Northx Nickel Corp: Northx enters definitive deal to sell Sudbury portfolio
Mi	NorthX Nickel Corp.: NorthX Nickel Announces Agreement to Sell Sudbury Portfolio	Vancouver, British Columbia--(Newsfile Corp. - December 18, 2024) - NorthX Nickel Corp. (CSE: NIX) (OTCQB: NXNIF) (FSE: 6YR) (the "Company" or "NorthX") announces that it has entered into a definitive... ► Artikel lesen
04.12.	Amarna Therapeutics and NorthX Biologics Partner on Gene Therapy
04.11.	NEOGAP and NorthX Biologics partner for cancer cell therapy production
04.11.	NEOGAP THERAPEUTICS AB: Neogap Therapeutics partners with NorthX Biologics to advance scalable manufacturing for its novel cancer cell therapy

Zeit

Aktuelle Nachrichten

Northx Nickel Corp: Northx enters definitive deal to sell Sudbury portfolio

NorthX Nickel Corp.: NorthX Nickel Announces Agreement to Sell Sudbury Portfolio

Vancouver, British Columbia--(Newsfile Corp. - December 18, 2024) - NorthX Nickel Corp. (CSE: NIX) (OTCQB: NXNIF) (FSE: 6YR) (the "Company" or "NorthX") announces that it has entered into a definitive...
► Artikel lesen

04.12.

Amarna Therapeutics and NorthX Biologics Partner on Gene Therapy

04.11.

NEOGAP and NorthX Biologics partner for cancer cell therapy production

04.11.

NEOGAP THERAPEUTICS AB: Neogap Therapeutics partners with NorthX Biologics to advance scalable manufacturing for its novel cancer cell therapy

Zeit	Aktuelle Nachrichten
Mo	SAFE & GREEN HOLDINGS CORP. - 8-K, Current Report
04.12.	Safe & Green Holdings shares climb on two new contracts for modular construction projects
04.12.	Safe & Green Holdings secures two modular contracts
04.12.	Safe & Green Holdings Corp. Secures Two New Contracts for Modular Construction Projects
02.12.	What's Going On With Safe & Green Holdings (SGBX) Stock?

Zeit

Aktuelle Nachrichten

SAFE & GREEN HOLDINGS CORP. - 8-K, Current Report

04.12.

Safe & Green Holdings shares climb on two new contracts for modular construction projects

04.12.

Safe & Green Holdings secures two modular contracts

04.12.

Safe & Green Holdings Corp. Secures Two New Contracts for Modular Construction Projects

02.12.

What's Going On With Safe & Green Holdings (SGBX) Stock?

Zeit	Aktuelle Nachrichten
06.12.	YIELD10 BIOSCIENCE, INC. - 8-K, Current Report
22.11.	YIELD10 BIOSCIENCE, INC. - 8-K, Current Report
12.11.	YIELD10 BIOSCIENCE, INC. - 8-K, Current Report
08.11.	Yield10 Bioscience, Inc.: Yield10 Bioscience Announces Adjournment of Special Meeting of Stockholders to Solicit Sufficient Votes in Favor of the Key Proposals	Special Meeting Adjourned to Thursday, November 21, 2024 WOBURN, MA / ACCESSWIRE / November 8, 2024 / Yield10 Bioscience, Inc. (OTCQB:YTEN) ("Yield10" or the "Company"), an agricultural bioscience... ► Artikel lesen
31.10.	YIELD10 BIOSCIENCE, INC. - 8-K, Current Report

Zeit

Aktuelle Nachrichten

06.12.

YIELD10 BIOSCIENCE, INC. - 8-K, Current Report

22.11.

YIELD10 BIOSCIENCE, INC. - 8-K, Current Report

12.11.

YIELD10 BIOSCIENCE, INC. - 8-K, Current Report

08.11.

Yield10 Bioscience, Inc.: Yield10 Bioscience Announces Adjournment of Special Meeting of Stockholders to Solicit Sufficient Votes in Favor of the Key Proposals

Special Meeting Adjourned to Thursday, November 21, 2024 WOBURN, MA / ACCESSWIRE / November 8, 2024 / Yield10 Bioscience, Inc. (OTCQB:YTEN) ("Yield10" or the "Company"), an agricultural bioscience...
► Artikel lesen

31.10.

YIELD10 BIOSCIENCE, INC. - 8-K, Current Report

Unternehmen / Aktien	Kurs	%
ARCIMOTO INC	0,329	0,00 %
BIOPHYTIS SA	0,320	+1,27 %
BWX LIMITED	-	-
COSCIENS BIOPHARMA INC	2,700	+8,00 %
ENDO INC	-	-
GOLD-ZACK AG	0,004	0,00 %
NORTHX NICKEL CORP	0,028	+1,85 %
SAFE & GREEN HOLDINGS CORP	0,475	+16,08 %
YIELD10 BIOSCIENCE INC	0,184	0,00 %

Unternehmen / Aktien

Kurs

ARCIMOTO INC

0,329

0,00 %

BIOPHYTIS SA

0,320

+1,27 %

BWX LIMITED

COSCIENS BIOPHARMA INC

2,700

+8,00 %